Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway

Frontiers in Pharmacology 2026 Open access

Read full text
Authors: Weili Liao, Rui Fan, Yuman Du, Hairong Wang, Yong Sook Yang, Yuan Tian
DOI: 10.3389/fphar.2025.1764700
Cited by: 0

Abstract

[This corrects the article DOI: 10.3389/fphar.2025.1648623.].

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Psoriasis: Treatment and Pathogenesis Acute Kidney Injury Research

Publication details

Journal / source
Frontiers in Pharmacology
Volume
16
Pages
1764700–1764700
Publication date
2 January 2026
Language
EN